Диссертация (1140247), страница 15
Текст из файла (страница 15)
– №1. – С. 18-24.9.Махов В.М., Турко Т.В., Володина Т.В., Кулеш И.А. Ингибиторыпротонной помпы - основное звено в лечении кислотозависимой патологии// РМЖ. Гастроэнтерология. – 2013. – №13. – С. 698-701.10. МаховВ.М.,РомасенкоЛ.В.,ТуркоТ.В.,МамонтоваВ.В.Междисциплинарный подход к синдрому раздраженного кишечника //РМЖ. – 2013. №13. С. 702.11. Мнацаканян М.Г., Тащян О.В., Морозова Ю.Н., Погромов А.П., ДюковаГ.М., Халяпина Д.В.
Поражения пищевода при синдроме раздраженногокишечника \\ Журнал “Российский журнал гастроэнтерологии, гепатологиии колопроктологии”, РФ, № 5, 2015; 25-31.12. Мнацаканян М.Г., Погромов А.П., Зуев В.М., Дюкова Г.М., Тащян О.В.Синдром раздраженного кишечника у женщин репродуктивного именопаузального возраста. \\ Журнал “Сеченовский вестник”, № 3(25),2016; 70-78.13. Плотникова Е.Ю., Вологжанина Л.Г., Самсонов А.А., Самсонова О.А.,Андреев Д.Н. Маркеры гастроэзофагеальной рефлюксной болезни в теориии на практике // Фарматека. 2016. № 15. С. 25–33.14.
ПогромовА.П.,МнацаканянМ.Г.,ТащянО.В.Квопросураспространенности синдрома раздраженного кишечника в РоссийскойФедерации.\\ Журнал “Клиническая медицина”, РФ, №11, 2016, 869-874.15. Решетников О.В., Курилович С.А., Bobac M. и др. Желудочно-кишечныесимптомы у взрослого населения Новосибирска: распространенность ифакторы риска // Терапевтический архив. -2009. - № 2. – С. 11-16.16. Самсонов А.А., Андреев Д.Н., Дичева Д.Т. Синдром раздраженногокишечника с позиций современной гастроэнтерологии // Фарматека. -2014.- № 18. – С. 7-14.9117. Степанов Ю.М., Ратчик В.М., Пролом Н.В., Галинский А.А., ТарабаровС.А.
Манометрия в исследовании двигательной функции верхних отделовпищеварительной системы // Гастроэнтерология. 2017. Том 51. №2.18. Сторонова О.А., Трухманов А.С. Методика изучения двигательнойфункции пищевода. Пособие для последипломного образования / Под ред.Акад. РАМН, проф. В.Т.
Ивашкина. – М. – 2011. – 36 с.19. ТащянО.В.Коморбидныесимптомыиэмоционально-личностныеособенности у больных синдромом раздраженного кишечника (СРК) ивоспалительными заболеваниями кишечника в стадии ремиссии с СРКподобными симптомами: автореф. дис. … канд. мед. наук. – Москва, 2017.– 24 с.20. Фирсова Л.Д., Пичугина И.М., Янова О.Б. и др. Клинико-патогенетическиеособенности эзофагоспазма // Терапевтический архив.
– 2015. - №4. С. 3640.21. Achem SR, Almansa C, Krishna M, et al. Oesophageal eosinophilic infiltrationin patients with noncardiac chest pain. Aliment Pharmacol Ther 2011; 33:11941201.22. Ang D, Sifrim D, Tack J. Mechanisms of heartburn. Nat Clin Pract GastroenterolHepatol. 2008 Jul; 5(7):383-92.23. Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functionalesophageal disorders. Gastroenterology. 2016; 150:1368–1379.24. Bajbouj M, Becker V, Eckel F, et al. Argon plasma coagulation of cervicalheterotopic gastric mucosa as an alternative treatment for globus sensations.Gastroenterology 2009; 137:440-444.25.
Bashashati M, Hejazi RA, Andrews CN, Storr MA. Gastroesophageal refluxsymptoms not responding to proton pump inhibitor: GERD, NERD, NARD,esophageal hypersensitivity or dyspepsia? Can J Gastroenterol Hepatol. 2014Jun; 28(6):335-41.9226. Battaglia E, Bassotti G, Buonafede G, et al. Noncardiac chest pain of esophagealorigininpatientswithandwithoutcoronaryarterydisease.Hepatogastroenterology 2005; 52:792-795.27. Bharadwaj S, Barber MD, Graff LA, Shen B. Symptomatology of irritable bowelsyndrome and inflammatory bowel disease during the menstrual cycle.Gastroenterol Rep (Oxf).
2015 Aug; 3(3):185-93.28. Bogte A, Bredenoord AJ, Oors J, et al. Sensation of stasis is poorly correlatedwith impaired esophageal bolus transport. Neurogastroenterol Motil 2013;26:538-545.29. Botha C, Farmer AD, Nilsson M, et al. Preliminary report: modulation ofparasympatheticnervoussystemtoneinfluencesoesophagealpainhypersensitivity. Gut 2015; 64:611-617.30. Bredenoord AJ, Fox M, Kahrilas PJ, et al.
Chicago Classification criteria ofesophageal motility disorders defined in high resolution esophageal pressuretopography. Neurogastroenterol Motil 2012; 24 Suppl 1:57-65.31. Bredenoord AJ, Weusten BL, Timmer R, et al. Addition of esophagealimpedance monitoring to pH monitoring increases the yield of symptomassociation analysis in patients off PPI therapy. Am J Gastroenterol 2006;101:453-459.32. Camacho-Lobato L, Katz PO, Eveland J, et al. Vigorous achalasia: originaldescription requires minor change.
J Clin Gastroenterol 2001; 33:375-377.33. Chang L. Review article: epidemiology and quality of life in functionalgastrointestinal disorders. Aliment Pharmacol Ther. 2004 Nov; 20 Suppl 7:31-9.34. Chen CL, Szczesniak MM, Cook IJ. Evidence for oesophageal visceralhypersensitivity and aberrant symptom referral in patients with globus.Neurogastroenterol Motil 2009; 21:1142-e1196.35. Cheung TK, Lam KF, Hu WH, Lam CL, Wong WM, Hui WM, et al. Positiveassociation between gastrooesophageal reflux disease and irritable bowelsyndrome in a Chinese population.
Aliment Pharmacol Ther 2007; 25:1099-104.9336. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap ofdyspepsia and gastroesophageal reflux in the general population: One disease ordistinct entities? Neurogastroenterol Motil 2012; 24:229-34, e106.37. Coghill R, McHaffie J, Yen Y. Neural correlates of interindividual differences inthe subjective experience of pain. Proc Natl Acad Sci U S A 2003; 100:85388542.38. Colon VJ, Young MA, Ramirez FC. The short- and long-term efficacy ofempirical esophageal dilation in patients with nonobstructive dysphagia: aprospective, randomized study.
Am J Gastroenterol 2000; 95:910-913.39. Costantini M, Sturniolo GC, Zaninotto G, D’Inca R, Polo R, Naccarato R, et al.Altered esophageal pain threshold in irritable bowel syndrome. Dig Dis Sci1993; 38:206-12.40. Cremonini F, Wise J, Moayyedi P, et al. Diagnostic and therapeutic use of protonpump inhibitors in non-cardiac chest pain: a metaanalysis.
Am J Gastroenterol2005; 100:1226-1232.41. Daum C, Sweis R, Kaufman E, et al. Failure to respond to physiologic challengecharacterizes esophageal motility in erosive gastro-esophageal reflux disease.Neurogastroenterol Motil 2011; 23:517-e200.42. de Bortoli N, Frazzoni L, Savarino EV, Frazzoni M, Martinucci I, Jania A, et al.Functional heartburn overlaps with irritable bowel syndrome more often thanGERD.
Am J Gastroenterol 2016; 111:1711-7.43. de Bortoli N, Martinucci I, Bellini M, Savarino E, Savarino V, Blandizzi C,Marchi S. Overlap of functional heartburn and gastroesophageal reflux diseasewith irritable bowel syndrome. World J Gastroenterol. 2013 Sep 21;19(35):5787-97.44. de Bortoli N, Martinucci I, Savarino E, et al. Proton pump inhibitor responderswho are not confirmed as GERD patients with impedance and pH monitoring:who are they? Neurogastroenterol Motil 2014; 26:28-35.9445.
de Bortoli N, Martinucci I, Savarino E, et al. Association between baselineimpedance values and response proton pump inhibitors in patients withheartburn. Clin Gastroenterol Hepatol. 2015; 13:1082–1088. e1.46. de Bortoli N, Martinucci I, Savarino E, Franchi R, Bertani L, Russo S, CeccarelliL, Costa F, Bellini M, Blandizzi C, Savarino V, Marchi S. Lower pH values ofweaklyacidicrefluxesasdeterminantsofheartburnperceptioningastroesophageal reflux disease patients with normal esophageal acid exposure.Dis Esophagus. 2016 Jan; 29(1):3-9.47.
de Bortoli N, Natali V, Melissari S, Simonetti N, Tapete G, Marchi S. Overlap ofGERD and gastrointestinal functional disorders. Minerva Gastroenterol Dietol.2017 Sep; 63(3):205-220.48. de Bortoli N, Ottonello A, Zerbib F, Sifrim D, Gyawali CP, Savarino E. BetweenGERD and NERD: the relevance of weakly acidic reflux.
Ann N Y Acad Sci.2016 Sep; 1380(1):218-229.49. de Bortoli N, Penagini R, Savarino E, Marchi S. Eosinophilic esophagitis: updatein diagnosis and management. Position paper by the Italian Society ofGastroenterology and Gastrointestinal Endoscopy (SIGE). Dig Liver Dis. 2017;49:254–260.50. Deary IJ, Wilson JA, Harris MB, et al. Globus pharyngis: development of asymptom assessment scale. J Psychosom Res 1995; 39:203-213.51. Deary IJ, Wilson JA, Kelly SW. Globus pharyngis, personality, andpsychological distress in the general population. Psychosomatics 1995; 36:570577.52. Dekel R, Pearson T, Wendel C, et al.
Assessment of oesophageal motor functionin patients with dysphagia or chest pain - the Clinical Outcomes ResearchInitiative experience. Aliment Pharmacol Ther 2003; 18:1083-1089.53. Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: evidencedbased approach to the diagnosis and management of esophageal eosinophilia andeosinophilic esophagitis (EoE).
Am J Gastroenterol 2013; 108:679-692; quiz693.9554. Dickman R, Mattek N, Holub J, et al. Prevalence of upper gastrointestinal tractfindingsin patientswith noncardiac chest painversusthose withgastroesophageal reflux disease (GERD)-related symptoms: results from anational endoscopic database. Am J Gastroenterol 2007; 102:1173-1179.55. Drewes AM, Babenko L, Birket-Smith L, et al. Induction of non-painful andpainful intestinal sensations by hypertonic saline: a new human experimentalmodel. Eur J Pain 2003; 7:81-91.56. Drewes AM, Schipper KP, Dimcevski G, Petersen P, Andersen OK, GregersenH, et al. Multimodal assessment of pain in the esophagus: A new experimentalmodel.
Am J Physiol Gastrointest Liver Physiol 2002; 283:G95-103.57. Drossman DA. The functional gastrointestinal disorders and the Rome IIIprocess. In: Drossman DA, Corazziari E, Delvaux M, et al., eds. Rome III: thefunctional gastrointestinal disorders. 3rd edition. McLean (VA): DegnonAssociates, Inc., 2006.58. Drossman DA. Presidential address: gastrointestinal illness and biopsychosocialmodel.
Psychosom Med 1998; 60: 258-267.59. Drossman DA. Biopsychosocial issues in gastroenterology. In: Feldman M,Friedman LS, and Brandt LJ, eds. Sleisenger and Fordtran’s gastrointestinal andliver disease. 10th ed. Philadelphia: Saunders Elsevier, 2015: 349-362.60. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functionalgastro¬intestinal disorders. Prevalence, sociodemography, and health impact.Dig Dis Sri 1993; 38:1569-1580.61.